CA3056293A1 - Utilisation de l'oleoresine de copaifera dans les pathologies de la prostate - Google Patents
Utilisation de l'oleoresine de copaifera dans les pathologies de la prostate Download PDFInfo
- Publication number
- CA3056293A1 CA3056293A1 CA3056293A CA3056293A CA3056293A1 CA 3056293 A1 CA3056293 A1 CA 3056293A1 CA 3056293 A CA3056293 A CA 3056293A CA 3056293 A CA3056293 A CA 3056293A CA 3056293 A1 CA3056293 A1 CA 3056293A1
- Authority
- CA
- Canada
- Prior art keywords
- oleoresin
- copaifera
- prostate
- acid
- diterpenic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1752284 | 2017-03-20 | ||
| FR1752284A FR3063906B1 (fr) | 2017-03-20 | 2017-03-20 | Utilisation de l'oleoresine de copaifera dans les pathologies de la prostate |
| PCT/EP2018/057076 WO2018172380A1 (fr) | 2017-03-20 | 2018-03-20 | Utilisation de l'oleoresine de copaifera dans les pathologies de la prostate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3056293A1 true CA3056293A1 (fr) | 2018-09-27 |
Family
ID=59153043
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3056293A Pending CA3056293A1 (fr) | 2017-03-20 | 2018-03-20 | Utilisation de l'oleoresine de copaifera dans les pathologies de la prostate |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11311591B2 (https=) |
| EP (1) | EP3600370B1 (https=) |
| JP (1) | JP7305546B2 (https=) |
| KR (1) | KR102686593B1 (https=) |
| CN (1) | CN110494149A (https=) |
| AU (1) | AU2018240405B2 (https=) |
| BR (1) | BR112019018744B1 (https=) |
| CA (1) | CA3056293A1 (https=) |
| ES (1) | ES2979106T3 (https=) |
| FR (1) | FR3063906B1 (https=) |
| MA (1) | MA48970B1 (https=) |
| MX (1) | MX2019011118A (https=) |
| PL (1) | PL3600370T3 (https=) |
| WO (1) | WO2018172380A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020089944A1 (en) * | 2018-11-03 | 2020-05-07 | Olene Life Sciences Private Limited | Process for preparing an herbal extract and compositions thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH698144B1 (fr) * | 2003-09-24 | 2009-05-29 | Bioxell Spa | Analogue de la vitamine D3 |
-
2017
- 2017-03-20 FR FR1752284A patent/FR3063906B1/fr active Active
-
2018
- 2018-03-20 CA CA3056293A patent/CA3056293A1/fr active Pending
- 2018-03-20 MX MX2019011118A patent/MX2019011118A/es unknown
- 2018-03-20 BR BR112019018744-8A patent/BR112019018744B1/pt active IP Right Grant
- 2018-03-20 PL PL18711130.7T patent/PL3600370T3/pl unknown
- 2018-03-20 US US16/495,771 patent/US11311591B2/en active Active
- 2018-03-20 WO PCT/EP2018/057076 patent/WO2018172380A1/fr not_active Ceased
- 2018-03-20 ES ES18711130T patent/ES2979106T3/es active Active
- 2018-03-20 MA MA48970A patent/MA48970B1/fr unknown
- 2018-03-20 EP EP18711130.7A patent/EP3600370B1/fr active Active
- 2018-03-20 AU AU2018240405A patent/AU2018240405B2/en active Active
- 2018-03-20 KR KR1020197028071A patent/KR102686593B1/ko active Active
- 2018-03-20 CN CN201880018902.4A patent/CN110494149A/zh active Pending
- 2018-03-20 JP JP2019551555A patent/JP7305546B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2019132832A3 (https=) | 2021-06-11 |
| MA48970A (fr) | 2021-03-31 |
| EP3600370B1 (fr) | 2024-04-03 |
| BR112019018744A2 (pt) | 2020-04-07 |
| FR3063906B1 (fr) | 2025-12-12 |
| JP2020511488A (ja) | 2020-04-16 |
| PL3600370T3 (pl) | 2024-07-29 |
| BR112019018744B1 (pt) | 2023-02-23 |
| KR102686593B1 (ko) | 2024-07-18 |
| KR20190126091A (ko) | 2019-11-08 |
| AU2018240405A1 (en) | 2019-11-07 |
| RU2019132832A (ru) | 2021-04-21 |
| EP3600370C0 (fr) | 2024-04-03 |
| EP3600370A1 (fr) | 2020-02-05 |
| FR3063906A1 (fr) | 2018-09-21 |
| ES2979106T3 (es) | 2024-09-24 |
| AU2018240405B2 (en) | 2024-04-11 |
| US20200093879A1 (en) | 2020-03-26 |
| WO2018172380A1 (fr) | 2018-09-27 |
| MA48970B1 (fr) | 2024-06-28 |
| US11311591B2 (en) | 2022-04-26 |
| CN110494149A (zh) | 2019-11-22 |
| MX2019011118A (es) | 2019-11-05 |
| JP7305546B2 (ja) | 2023-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2459661A1 (fr) | Nouvelle composition medicamenteuse a base de plantes, et procede de preparation | |
| WO2018172379A1 (fr) | Utilisation d'un extrait de copaifera contre l'alopecie et la seborrhee | |
| FR2892933A1 (fr) | Extrait vegetal obtenu par un procede d'extraction a l'aide de solvants d'origine vegetale | |
| FR3047175A1 (fr) | Compositions cosmetiques, dermatologiques comprenant un extrait de vitex negundo enrichi en polyphenols | |
| EP1014927B1 (fr) | Utilisation des shogaols et des gingerols pour la preparation de compositions deodorantes | |
| OA10508A (fr) | Substances extraites de dictyotales leur procédé d'obtention et les compositions en renfermant | |
| EP3600370B1 (fr) | Utilisation de l'oleoresine de copaifera dans les pathologies de la prostate | |
| WO2012007670A2 (fr) | Composition cosmetique ou dermatologique et son utilisation, pour le soin de la peau des hommes jeunes | |
| FR2700956A1 (fr) | Composition cosmétique et pharmaceutique et procédé pour sa préparation. | |
| EP4380590A1 (fr) | Composition a base de crocus sativus et de cannabis sativa | |
| FR2821553A1 (fr) | Utilisation d'un ou plusieurs shogaol (s) en tant qu'aphrodisiaque | |
| EP2139503B1 (fr) | Compositions cosmetiques et dermatologiques a base d'extraits d'algues | |
| RU2773173C2 (ru) | Применение олеорезинов копаиферы при патологиях простаты | |
| EP3965790B1 (fr) | Triterpènes pentacycliques dans le traitement du vitiligo | |
| FR2930728A1 (fr) | Utilisation dans le domaine de la cosmetique d'un extrait d'un exsudat de la plante daniellia oliveri, en particulier comme agent anti-rides | |
| BE1026269B1 (fr) | Formulation à propriétés anti-inflammatoires | |
| WO2025125625A1 (fr) | Extrait de verbena officinalis pour la prévention et/ou le traitement de la chute des cheveux | |
| EP4494647A1 (fr) | Extrait d akènes de silybum marianum (l.) gaertn. pour le traitement ou la prévention de rougeurs cutanées | |
| FR3018685B1 (fr) | Applications cosmetiques et pharmaceutiques de la salicaire | |
| WO2025011789A1 (fr) | Extrait de rose de damas riche en polyphenols obtenu a partir d'un coproduit d'hydrodistillation et ses utilisations comme complement alimentaire | |
| HK40017918A (en) | Use of copaifera oleoresin in pathologies of the prostate | |
| Mbaïhougadobe et al. | Inventaire et essais phytochimiques sur quelques plantes du Tchad utilisées dans le traitement de la goutte | |
| BE1027772A1 (fr) | Composition de ginseng pour ameliorer l'etat de la peau et son utilisation pour le traitement d'une maladie dermatologique | |
| FR3037244A1 (fr) | Compositions cosmetiques, nutraceutiques, veterinaires et pharmaceutiques contenant un extrait de pericarpe de noisette |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20230228 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D00-D120 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: VOLUNTARY SUBMISSION OF PRIOR ART RECEIVED Effective date: 20240808 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20240808 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250213 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 7TH ANNIV.) - STANDARD Year of fee payment: 7 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250226 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20250226 Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250226 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D00-D123 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRIOR ART DISCLOSURE DETERMINED COMPLIANT Effective date: 20250401 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250401 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250401 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250401 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20250731 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20251124 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20260108 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20260108 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20260108 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 8TH ANNIV.) - STANDARD Year of fee payment: 8 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260223 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260223 |